Disease Markers
Volume 2019 (2019), Article ID 4976845, 12 pages
https://doi.org/10.1155/2019/4976845

Research Article

The Increased lncRNA MIR503HG in Preeclampsia Modulated Trophoblast Cell Proliferation, Invasion, and Migration via Regulating Matrix Metalloproteinases and NF-κB Signaling

Dan Cheng,¹ Shan Jiang,² Jiao Chen,¹ Jie Li,¹ Liangfei Ao,¹ and Ying Zhang¹

¹Center for Reproductive Medicine, Renmin Hospital of Wuhan University, Hubei Clinic Research Center for Assisted Reproductive Technology and Embryonic Development, Wuhan, 430060 Hebei Province, China
²Department of Dermatology, Renmin Hospital of Wuhan University, Wuhan, 430060 Hebei Province, China

Correspondence should be addressed to Dan Cheng; chengdanny2018@sohu.com

Received 1 March 2019; Revised 30 May 2019; Accepted 24 June 2019; Published 30 July 2019

Academic Editor: Yvan Devaux

Copyright © 2019 Dan Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. Preeclampsia (PE) is a pregnancy-related syndrome characterized by hypertension and proteinuria after the 20th week of gestation. The long noncoding RNAs (lncRNAs) have been recently discovered for their roles in the pathogenesis of PE. This study is aimed at determining the expression of lncRNA MIR503 host gene (MIR503HG) in PE placental tissues and exploring the molecular mechanism underlying MIR503HG-mediated trophoblast cell proliferation, invasion, and migration. Methods. The expression level of MIR503HG in placental tissues, HTR-8/SVneo, and JEG3 cells was determined by quantitative real-time PCR; western blot detected the relevant protein expression levels in HTR-8/SVneo and JEG3 cells; flow cytometry determined cell apoptosis and cell cycle of HTR-8/SVneo and JEG3 cells; trophoblast cell proliferation, invasion, and migration of HTR-8/SVneo and JEG3 cells were measured by CCK-8, transwell invasion, and wound healing assays, respectively. Results. The highly expressed MIR503HG was detected in PE placental tissues compared to normal placental tissues. MIR503HG overexpression suppressed cell proliferation, invasion, and migration of HTR-8/SVneo and JEG3 cells, while knockdown of MIR503HG increased trophoblast cell proliferation, invasion, and migration. Flow cytometry results showed that MIR503HG overexpression induced apoptosis and caused cell cycle arrest at the G₀/G₁ phase, while MIR503HG knockdown had the opposite actions in HTR-8/SVneo and JEG3 cells. Western blot assay results showed that MIR503HG overexpression suppressed the matrix metalloproteinase-2/-9 and the snail protein expression and increased the E-cadherin expression in trophoblast cells. In addition, MIR503HG overexpression suppressed the NF-κB signaling pathway by inhibiting the phosphorylation of IκBα and the nuclear translocation of NF-κB signaling subunit p65. On the other hand, MIR503HG knockdown played an opposite role in these protein expression levels. Conclusion. Our results showed that MIR503HG inhibited the proliferation, invasion, and migration of HTR-8/SVneo and JEG3 cells, which may be related to the pathogenesis of PE.

1. Introduction

Preeclampsia (PE) is a pregnancy-related syndrome characterized by hypertension and proteinuria after the 20th week of gestation [1], and PE affects about 4% of pregnancies and accounts for more than 15% maternal mortality worldwide [2]. Normal proliferation and differentiation of human placental trophoblasts are important in maintaining the proper function of the placenta [3]. Inadequate trophoblast cell invasion and migration was found to be associated with PE [4]. The deficiencies in trophoblast invasion and migration are the main contributors of the PE pathogenesis, and in the early stage of PE, the inadequate invasion of trophoblast cells leads to the impairment of vascular remodeling and the decrease in the circulation of the early placenta, which consequently causes placental ischemia after the 20th week of gestation [5]. In addition, increased apoptosis of placental trophoblasts within the uterine wall was also demonstrated to involve in the pathogenesis of PE [6]. Up to date, proangiogenic and antiangiogenic factors in the circulation, including placental growth factor, endoglin, and fms-related tyrosine kinase 1, were indicated to play important roles in the pathogenesis of PE [7]. However, the molecular mechanisms underlying PE pathogenesis remain unclear.

Long noncoding RNAs (lncRNAs) are RNA species more than 200 nucleotides in length and lack protein-coding potential [8]. lncRNAs have been found to play important roles in the pathogenesis of various diseases, particularly in cancer [9]. Recently, multiple studies showed the differential expression of lncRNAs in the PE placentas, suggesting that lncRNA may contribute to the pathogenesis of PE [10]. The loss of the lncRNA H19 gene imprinting in the placental tissues of PE patients was found to be associated with severe hypertension, which may contribute to the pathogenic process of PE [11]. The lncRNA-maternally expressed gene 3 (MEG3) was found to be downregulated in placental samples from PE patients, and abnormal levels of MEG3 were shown to result in cellular dysfunctions of HTR-8/SVneo and JEG3 trophoblast cells [12]. Zou et al. identified the upregulation of lncRNA SPRY4 intronic transcript 1 (SPRY4-IT1) in PE placental tissues, and SPRY4-IT1 regulated trophoblast cell invasion and migration by affecting the epithelial-mesenchymal transition [13]. Xu et al. also found that lncRNA taurine upregulated 1 modulated proliferation in trophoblast cells via epigenetic suppression of the Rho family GTPase 3 [14]. Recent studies showed that placenta-enriched lncRNA MIR503 host gene (MIR503HG) decreased the migration and invasion potential of JEG3 cell line [15], suggesting a potential role for MIR503HG in the PE. However, the exact role of MIR503HG in the pathogenesis of PE has not been investigated so far.

In the present study, we intended to discover the possible roles of MIR503HG in trophoblast proliferation, invasion, and migration. The elevation of placental MIR503HG was identified in severe PE placental tissues. In addition, the effects of MIR503HG on cellular functions were also explored using in vitro studies.

2. Materials and Methods

2.1. Sample Collection

Forty severe PE pregnant subjects and 40 normal pregnant subjects were recruited at the moment of admission to Renmin Hospital of Wuhan University. Diagnosis of severe PE was based on the definition in Williams Obstetrics (23rd edition) [16]. Pregnant patients (more than 20 weeks of gestation) with no history of preexisting/chronic hypertension exhibited systolic/diastolic on 2 separate readings, proteinuria measurement of 1+ or more times, or 24 h urine protein collection with ≥300 mg. Subjects with disorders such as diabetes, lupus, urinary tract infection, or chronic renal disease were excluded from this study. All pregnancies were treated by elective cesarean delivery in the absence of labor, and the placental tissues were collected within 1 h of cesarean birth and stored in -80°C for further use. All the research procedures were approved by the Ethics Committee of Renmin Hospital of Wuhan University, and informed consent was obtained from all the participated subjects.

2.2. Cell Line and Cell Culture

The human trophoblast cell lines including HTR-8/SVneo and JEG3 cells (HTR-8/SVneo: derived by transfecting the cells that grew out of the chorionic villi explants of human first-trimester placenta with the gene encoding for simian virus 40 large T antigen; JEG3 cells: derived from a human choriocarcinoma and presented many of the biological and biochemical characteristics associated with syncytiotrophoblasts) were purchased from the American Type Culture Collection company (Manassas, VA, USA) and cultured in RPMI 1640 medium (Thermo Fisher Scientific, Waltham, CA, USA) containing 10% fetal bovine serum (FBS; Thermo Fisher Scientific), 100 μg/ml streptomycin, and 100 UI/ml penicillin. Cells were incubated at 37°C with 5% CO₂ and routinely passaged every 3 d.

2.3. Plasmids, siRNAs, and Cell Transfection

The pcDNA3.1 vector was used to generate MIR503HG-overexpressing vector, and the empty vector, pcDNA3.1, and MIR503HG-overexpressing vector (pcDNA3.1-MIR503HG) were purchased from GeneChem (Shanghai, China). The siRNAs targeting MIR503HG (si-MIR503HG) and the scrambled negative controls (si-NC) were purchased from RiboBio (Guangzhou, China). For plasmid and siRNA transfection, trophoblast cells of a confluent cell monolayer were transiently transfected with plasmids (20 μg) or siRNAs (100 nM) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instruction. At 24 h after transfection, cells were processed for further experimentation.

2.4. Quantitative Real-Time PCR (qRT-PCR)

Total RNA from placental tissues and cells was extracted using TRIzol reagent (Invitrogen), and the synthesis of cDNA was performed by the reverse transcription kit (Takara, Dalian, China). The amplification of cDNA was performed using Power SYBR green (Takara) in a reaction mix for real-time PCR on the ABI7900 system (Applied Biosystems, Waltham, MA, USA). The gene expression levels were quantified by the comparative Ct method, and analytical data were normalized to the mRNA expression level of glyceraldehyde-3-phosphate dehydrogenase. The primers for the real-time PCR were as follows: MIR503HG, forward, 5-CTTGAAGGCATCCAGCATCTC-3 and reverse, 5-TTGGGACACTTGGGTGGTTTT-3; GAPDH, forward, 5-CGCTCTCTGCTCCTCCTGTTC-3 and reverse, 5-ATCCGTTGACTCCGACCTTCAC-3.

2.5. Cell Counting Kit-8 (CCK-8) Assay

The transfected cells were seeded in the 96-well plates, and CCK-8 assays were performed at 0, 24, 48, 72, and 96 h after seeding. For the assay, culture medium was replaced with 100 μl of CCK-8 solution (Beyotime, Beijing, China) and incubated for 2 h at room temperature. The cell proliferation index was detected by measuring optical density (OD) values at the wavelength of 450 nm via the Microplate Reader (Thermo Fisher Scientific).

2.6. Transwell Invasion Assay

The transfected cells were suspended in 200 μl RPMI 1640 medium without FBS and seeded in the upper compartment Transwell inserts (8 μm in pore size, Millipore, Burlington, USA) coated with Matrigel, whereas the lower chamber was filled with full medium. After 24 h incubation at 37°C, noninvasive cells attaching to the top side of the inserts were cleaned by cotton swabs and the invasive cells were fixed with 4% paraformaldehyde and stained with 0.5% crystal violet for 10 min at room temperature. Stained cells were photographed and counted by using a light microscope (Leica, Heidelberg, Germany).

2.7. Wound Healing Assay

The transfected cells were seeded in the 6-well plates and subjected to serum starvation for 4 h. Then, a straight scratch in a cell monolayer was made by a sterile 200 μl pipette tip to simulate a wound. The scratched monolayer was then rinsed twice with a serum-free medium gently and allowed to heal in a complete medium for 24 h. The wound width was photographed using an inverted microscope at 0 and 24 h after wound formation, respectively. Cell migration was evaluated by the measurement of % wound closure.

2.8. Flow Cytometry

For cell cycle determination, transfected cells were collected and washed with cold phosphate-buffered saline (PBS), and cells were fixed with 70% ethanol. Thereafter, cells were stained with propidium iodide (PI) staining solution in PBS for 15 min at 37°C. Stained cells were analyzed for cell cycle distribution by using BD FACSCanto II (BD Biosciences, San Jose, CA, USA).

For cell apoptosis determination, apoptotic cells were detected by Annexin V-FITC/PI double staining using the Annexin V-FITC Apoptosis Detection Kit (Thermo Fisher Scientific) according to the manufacturer’s instruction. Briefly, transfected cells were collected and washed with cold PBS, and cells then were stained with Annexin V-FITC and PI in binding buffer for 10 min. The stained cells were then analyzed using BD FACSCanto (BD Biosciences).

2.9. Western Blot

Proteins from cells were extracted using radioimmunoprecipitation assay lysis buffer (Beyotime), and the proteins in nuclear fractions were prepared with the NE-PER extraction kit (Thermo Fisher Scientific) according to the manufacturer’s instruction. The extracted protein was resolved in sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride (PVDF) membranes. The PVDF membranes were blocked with 5% skimmed milk and incubated with appropriated primary antibodies at 4°C overnight. Thereafter, the PVDF membranes were incubated with horseradish peroxidase-conjugated secondary antibodies. Protein blots were visualized by using the ECL-Plus western blotting detection system (Thermo Fisher Scientific). The used primary antibodies include rabbit polyclonal antibodies for matrix metalloproteinase-2 (MMP2; 1 : 1500; Cell Signaling Technology, Danvers, MA, USA), MMP9 (1 : 1500; Cell Signaling Technology), snail (1 : 1000; Abcam, Cambridge, UK), E-cadherin (1 : 1000; Abcam), p65 (1 : 500; Cell Signaling Technology), IκBα (1 : 500; Cell Signaling Technology), and lamin A (1 : 1500; Abcam) and rabbit monoclonal antibodies for phosphorylated IκBα (1 : 1000; Cell Signaling Technology) and β-actin (1 : 2000; Abcam).

2.10. Statistical Analysis

Statistical analysis was performed using SPSS 19.0 statistical software (IBM SPSS, Armonk, NY, USA). All experiments were performed with 3 technical repeats, deriving from at least 3 individual experiments, and the data were presented as . Student’s -test was performed to estimate the significance of the differences caused by treatments relative to their corresponding controls. was considered statistically significant.

3. Results

3.1. The Expression of MIR503HG Was Upregulated in PE Placental Specimens

The clinical characteristics of the pregnant women who participated in this study are shown in Table 1. The systolic blood pressure and diastolic blood pressure were significantly higher in the PE group in comparison with the control group. Furthermore, proteinuria was detected in the PE group but not in the control group. In addition, the birth weight of the newborns in the PE group was lower than that in the control group. The expression of MIR503HG in the placental tissues was determined by qRT-PCR assay, and the expression of MIR503HG in the placental tissues from the PE group was significantly higher than that from the control group (Figure 1), suggesting the potential roles of MIR503HG in PE.

Table 1: Clinical characteristics of pregnant women enrolled in this study.

Characteristics
Control ()
PE ()
value

Prepregnancy BMI

0.1163

Maternal age (years old)

0.8151

Systolic blood pressure (mmHg)

Diastolic blood pressure (mmHg)

Proteinuria (g/24 h)
Nondetected

Current smoker
0
0
NA

Gestational age (weeks)

0.0782

Birth weight (g)

BM: body mass index.

Figure 1: The expression level of MIR503HG in placental tissues. The relative expression level of MIR503HG in placental tissues from normal pregnant women () and women with severe PE () was measured by qRT-PCR assay. compared to the control group.

3.2. MIR503HG Suppressed Trophoblast Cell Proliferation, Invasion, and Migration

The overexpression of MIR503HG in HTR-8/SVneo and JEG3 cells was carried out by transfecting trophoblast cells with pcDNA3.1-MIR503HG, and the expression levels of MIR503HG in pcDNA3.1-MIR503HG-transfected trophoblast cells were significantly higher than that in pcDNA3.1 vector-transfected trophoblast cells (Figures 2(a) and 2(c)). The knockdown of MIR503HG in HTR-8/SVneo and JEG3 cells was carried out by transfecting trophoblast cells with MIR503HG siRNA (si-MIR503HG), and the expression levels of MIR503HG in si-MIR503HG-transfected trophoblast cells were significantly lower than that in si-NC-transfected cells (Figures 2(b) and 2(d)).

(a)

(b)

(c)

(d)

Figure 2: The expression of MIR503HG in trophoblast cells transfected with plasmids or siRNA. (a, b) qRT-PCR assays were implemented to measure the expression level of MIR503HG in HTR-8/SVneo cells transfected with pcDNA 3.1 (vector) or pcDNA3.1-MIR503HG (MIR503HG) and scrambled siRNA (si-NC) or MIR503HG siRNA (si-MIR503HG). (c, d) qRT-PCR assays were also performed in JEG3 cells after transfecting with the above-mentioned plasmids or siRNAs. , and compared to the corresponding control groups.

We subsequently assess the effects of MIR503HG overexpression on trophoblast cell proliferation by CCK-8 assay, and the cell proliferation of HTR-8/SVneo and JEG3 cells was significantly suppressed after pcDNA3.1-MIR503HG transfection (Figures 3(a) and 3(b)). The trophoblast invasion was assessed by Transwell invasion assay, and the number of invasive HTR-8/SVneo and JEG3 cells was significantly reduced after pcDNA3.1-MIR503HG transfection (Figures 3(c) and 3(d)). Furthermore, the cell migration was then assessed by wound healing assay, and the wound closure was significantly suppressed in HTR-8/SVneo and JEG3 cells transfected with pcDNA3.1-MIR503HG (Figures 3(e) and 3(f)).

(a)

(b)

(c)

(d)

(e)

(f)

Figure 3: Upregulation of MIR503HG suppressed trophoblast cell proliferation, invasion, and migration. (a, b) CCK-8 assays were performed to measure the cell proliferation of HTR-8/SVneo and JEG3 cells transfected with pcDNA3.1 or pcDNA3.1-MIR503HG. (c, d) Transwell invasion assays were performed to determine the cell invasion of HTR-8/SVneo and JEG3 cells transfected with pcDNA 3.1 or pcDNA3.1-MIR503HG. (e, f) Wound healing assays were performed to determine the cell migration of HTR-8/SVneo and JEG3 cells transfected with pcDNA3.1 or pcDNA3.1-MIR503HG. , , , and .

On the other hand, the cell proliferation, cell invasion, and cell migration of HTR-8/SVneo and JEG3 cells were significantly enhanced after MIR503HG siRNA transfection (Figures 4(a)–4(f)). Taken together, these results suggested that MIR503HG had suppressive effects on trophoblast cell proliferation, invasion, and migration.

(a)

(b)

(c)

(d)

(e)

(f)

Figure 4: Knockdown of MIR503HG promoted trophoblast cell proliferation, invasion, and migration. (a, b) CCK-8 assays were performed to measure the cell proliferation of HTR-8/SVneo and JEG3 cells transfected with scrambled siRNA or MIR503HG siRNA. (c, d) Transwell invasion assays were performed to determine the cell invasion of HTR-8/SVneo and JEG3 cells transfected with scrambled siRNA or MIR503HG siRNA. (e, f) Wound healing assays were performed to determine the cell migration of HTR-8/SVneo and JEG3 cells transfected with scrambled siRNA or MIR503HG siRNA. , and .

3.3. The Effects of MIR503HG Overexpression on Trophoblast Cell Apoptosis and Cell Cycle

To explore the role of MIR503HG in trophoblast cell apoptosis and cell cycle, we performed flow cytometry experiments. The cell apoptotic rate was significantly increased in HTR-8/SVneo and JEG3 cells after transfection with pcDNA3.1-MIR503HG (Figures 5(a) and 5(b)). The cell cycle analysis showed that overexpression of MIR503HG increased cell population at the G₀/G₁ phase and decreased cell population at the S phase in both HTR-8/SVneo and JEG3 cells (Figures 5(c) and 5(d)). On the other hand, knockdown of MIR5053HG reduced cell apoptosis and promoted cell cycle progression in both HTR-8/SVneo and JEG3 cells (Figures 5(e)–5(h)). Collectively, the results suggested that MIR503HG induced cell apoptosis and caused cell cycle arrest at the G₀/G₁ phase of trophoblast cells.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Figure 5: The effects of MIR503HG overexpression on trophoblast cell apoptosis and cell cycle. (a, b) Flow cytometry was performed to measure the cell apoptotic rate in HTR-8/SVneo and JEG3 cells after transfected with pcDNA 3.1 or pcDNA3.1-MIR503HG. (c, d) Flow cytometry was performed to determine the cell cycle in HTR-8/SVneo and JEG3 cells after transfected with pcDNA 3.1 or pcDNA3.1-MIR503HG. (e, f) Flow cytometry was performed to measure the cell apoptotic rate in HTR-8/SVneo and JEG3 cells after transfected with scrambled siRNA or MIR503HG siRNA. (g, h) Flow cytometry was performed to measure the cell cycle in HTR-8/SVneo and JEG3 cells after transfected with scrambled siRNA or MIR503HG siRNA. , .

3.4. MIR503HG Suppressed Matrix Metalloproteinases (MMPs) and Snail Protein Expression and Increased E-Cadherin Expression

MMPs are important mediators of vascular and uterine remodeling, and decreased expression of MMP2 and MMP9 have been suggested to involve in the hypertensive pregnancy and PE [17]. In addition, placental extravillous cytotrophoblast invasion involves a cellular transition from an epithelial to mesenchymal phenotype, and some of the epithelial-mesenchymal transition (EMT) regulators have been found to play an important role in the development of PE [18]. To further investigate the molecular mechanisms underlying MIR503HG-mediated trophoblast invasion and migration, we determined the protein levels of MMP2, MMP9, snail, and E-cadherin in trophoblast cells after MIR503HG overexpression or knockdown. As shown in Figure 6(a), overexpression of MIR503HG decreased the protein levels of MMP2, MMP9, and snail but increased the protein level of E-cadherin (Figure 6(a)), and knockdown of MIR503HG increased the protein levels of MMP2, MMP9, and snail but decreased the protein level of E-cadherin (Figure 6(b)). Consistently, similar findings regarding MMP2, MMP9, snail, and E-cadherin protein levels after MIR503HG overexpression or knockdown were demonstrated in JEG3 cells (Figures 6(c) and 6(d)).

(a)

(b)

(c)

(d)

Figure 6: MIR503HG suppressed MMPs and snail protein expression and increased E-cadherin expression. (a, b) Western blot assays were performed to determine the protein expression levels of MMP2, MMP9, snail, and E-cadherin in HTR-8/SVneo cells transfected with pcDNA 3.1 or pcDNA3.1-MIR503HG and scrambled siRNA or MIR503HG siRNA. (c, d) Western blot assays were also performed in JEG3 cells transfected with the above-mentioned plasmids or siRNAs. , .

3.5. MIR503HG Inhibited the NF-κB Signaling Pathway

Since the NF-κB signaling pathway was shown to be associated with the migratory ability of trophoblast cells, we further explored the effects of MIR503HG on NF-κB signaling by using western blot to detect the IκBα phosphorylation and nuclear NF-κB p65 translocation. As shown in Figure 7(a), overexpression of MIR503HG significantly reduced IκBα phosphorylation and inhibited nuclear NF-κB p65 translocation in HTR-8/SVneo cells (Figure 7(a)), and knockdown of MIR503HG significantly increased IκBα phosphorylation and nuclear NF-κB p65 translocation in HTR-8/SVneo cells (Figure 7(b)). Consistent results regarding the effects of MIR503HG on NF-κB signaling were also demonstrated in JEG3 cells (Figures 7(c) and 7(d)).

(a)

(b)

(c)

(d)

Figure 7: MIR503HG inhibited the NF-κB signaling pathway. (a, b) Western blot assays were performed to determine the protein expression levels of p-IκBα, IκBα, and nuclear NF-κB p65 in HTR-8/SVneo cells transfected with pcDNA 3.1 or pcDNA3.1-MIR503HG and scrambled siRNA or MIR503HG siRNA. (c, d) Western blot assays were also performed in JEG3 cells transfected with the above-mentioned plasmids or siRNAs. , .

4. Discussion

The placenta, a transient organ forming during pregnancy, supports the fetus growth and development [19]. Abnormal placental development, particularly the inadequate invasion of trophoblast cells into the uterus and the subsequent impairment of maternal spiral artery remodeling, plays important roles in the pathogenesis of PE [20]. Recently, the placenta-enriched lncRNA MIR503HG was expressed in placental tissues, and MIR503HG decreases the migration of JEG3 cells, indicating the involvement of MIR503HG in the pathogenesis of PE [15]; in addition, the dysregulation of MIR503HG may be related to epigenetic changes due to the presence of CpG islands in the promoter regions of MIR503HG [15]. In the present study, we consistently identified the highly expressed MIR503HG in placental tissues and in vitro functional assays showed that MIR503HG suppressed trophoblast cell proliferation, invasion, and migration, also induced apoptosis and cell cycle arrest at the G₀/G₁ phase. Further mechanistic study by using western blot assay showed that MIR503HG downregulated MMPs and inhibited the NF-κB signaling pathway in trophoblast cells.

Trophoblast cells physiologically invade into the uterus during pregnancy, and the trophoblast cell invasion was similar to the invasive behavior of tumor cells. Indeed, the expression level of MIR503HG was upregulated in hepatocellular carcinoma (HCC) tissues, and enhanced expression of MIR503HG inhibited HCC cell invasion and migration [21]. In the trophoblast cell line, JEG3, previous study showed that MIR503HG overexpression decreased JEG3 cell migration and invasion potential [15]. In addition, the effects of various lncRNAs on the trophoblast cell invasion and migration have been elucidated. The lncRNA plasmacytoma variant translocation 1 knockdown significantly suppressed cell proliferation, invasion, and migration and stimulated cell cycle accumulation and apoptosis [22]. The silencing of lncRNA microvascular invasion in hepatocellular carcinoma inhibited cell proliferation, invasion, migration, and angiogenesis in various trophoblast cell lines [23]. Inhibition of endogenous lncRNA activated by TGF-β suppressed HTR-8/SVneo cell proliferation, migration, and tube formation [24]. The trophoblast cell lines including HTR-8/SVneo and JEG3 are widely used as an in vitro model for studies on trophoblast cell behaviors. In the present study, we demonstrated that MIR503HG suppressed the invasion and migration in both HTR-8/SVneo and JEG3 cells, and these findings suggest that MIR503HG may contribute to the invasive and migratory capability of placental trophoblasts.

MMPs are zinc-dependent endopeptidases and play important roles in regulating cellular processes including the invasive behaviors of various types of cells [25]. MMP2 and MMP9 are important in human trophoblast cell invasion [26]. Peng et al. showed that gonadotrophin-releasing hormone regulated trophoblast invasion via Runt-related transcription factor 2-mediated MMP2 and MMP9 expression [27]. The expression levels of MMP2 and MMP9 in PE placentas were significantly downregulated when compared to normal placentas, suggesting the association between MMP2/9 and the pathogenesis of PE. In the present study, the MMP2 and MMP9 expressions were downregulated upon MIR503HG overexpression, while being upregulated upon MIR503HG knockdown in HTR-8/SVneo and JEG2 cells. Taken together, our results suggest that MMP2/9 may involve in the MIR503HG-mediated trophoblast cell invasion.

EMT is an important process in regulating the migratory behavior of trophoblast cells, and studies showed that EMT was suppressed in PE placentas [28]. In the present study, we examined the effects of MIR503HG on the protein expression of EMT-related factors including E-cadherin and snail. During the first trimester of pregnancy, E-cadherin is downregulated, which leads to the increased migratory ability of trophoblast [29]. E-cadherin can function as a negative regulator of migratory behavior of human trophoblast cells and is downregulated by cyclosporine A [30]. In the present study, we showed that MIR503HG increased the protein expression level of E-cadherin and decreased the protein expression level of snail. Collectively, these results suggest that MIR503 may contribute to EMT-related trophoblast migration.

Studies have shown that MIR503HG inhibits HCC cell invasion and migration via suppressing the NF-κB signaling pathway [21], suggesting the involvement of the NF-κB signaling pathway in MIR-503HG-mediated HCC cell invasion and migration. MIR503HG exerted its suppressive effects on the NF-κB signaling via promoting heterogeneous nuclear ribonucleoprotein A2/B1 degradation via the ubiquitin-proteasome pathway [21]. Studies from Yu et al. showed that knockdown of notch-1 inhibited migration and invasion and suppressed the NF-κB signaling pathway in trophoblast cells [31], implying the involvement of NF-κB signaling in trophoblast invasion and migration. In addition, the NF-κB signaling pathway was also found to regulate the MMP expression and EMT processes [32]. The activity of NF-κB signaling (evaluated by immunohistochemistry) was also found to be elevated by oxidative stress in the PE women [33], while in our study, MIR503HG exerted suppressive effects on the NF-κB in the trophoblast cells, and this contradiction may be attributed to differences in the cell types between different studies, which still requires further investigation. In our results, MIR503HG inhibited the phosphorylation of IκBα and the nuclear translocation of NF-κB signaling subunit p65, suggesting that NF-κB signaling may involve in the inhibitory effects of MIR503HG on trophoblast cell invasion and migration.

Several limitations should be considered for the present study. Firstly, the expression of MIR503HG in the placental tissues was only determined by qRT-PCR assay, and further immunohistochemistry may be performed to confirm the expression of MIR503HG in the placental tissues. Secondly, the expression levels of MMPs were not determined in the placental tissues due to the limited placental tissues, and further studies may be performed to determine the expression of these MMPs and their correlation with the MIR503HG expression. Thirdly, as lncRNAs exerted their functions via acting as competing endogenous RNA (ceRNA) for microRNAs [34], further investigation should be performed to determine whether MIR503HG functioned as a ceRNA to regulate the cellular functions of trophoblasts. More importantly, MIR503HG is the host gene of miR-503 and MIR503HG could induce the miR-503 expression in lymphoma [35], while miR-503 has been well-documented for its regulatory role in cell invasion and migration [36]. As such, future investigations should focus on the effects of MIR503HG on the miR-503 expression to further reveal the underlying mechanisms of MIR503HG in PE pathogenesis.

5. Conclusions

Our results showed that MIR503HG inhibited proliferation, invasion, and migration of HTR-8/SVneo and JEG3 cells, and the inhibitory effect of MIR503HG was related to the downregulation of MMPs and suppression of the NF-κB signaling pathway. The present study revealed the key role of MIR503HG in the invasive and migratory behaviors of trophoblasts, which may link to the pathogenesis of PE.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

This study was supported by the National Natural Science Foundation of China (No. 81801481), the Special Fund for Clinical Medical Research of the Chinese Medical Association-Research and Development Program for Young Physicians in Reproductive Medicine (No. 17020460715), and the Hubei Provincial Health and Family Planning Commission Youth Science and Technology Talent Project (No. WJ2015Q013).

References

M. Sircar, R. Thadhani, and S. A. Karumanchi, “Pathogenesis of preeclampsia,” Current Opinion in Nephrology and Hypertension, vol. 24, no. 2, pp. 131–138, 2015.

A. L. M. Sutton, L. M. Harper, and A. T. N. Tita, “Hypertensive disorders in pregnancy,” Obstetrics and Gynecology Clinics of North America, vol. 45, no. 2, pp. 333–347, 2018.

P. K. Lala and P. Nandi, “Mechanisms of trophoblast migration, endometrial angiogenesis in preeclampsia: the role of decorin,” Cell Adhesion & Migration, vol. 10, no. 1-2, pp. 111–125, 2016.

S. K. Gupta, S. S. Malhotra, A. Malik, S. Verma, and P. Chaudhary, “Cell signaling pathways involved during invasion and syncytialization of trophoblast cells,” American Journal of Reproductive Immunology, vol. 75, no. 3, pp. 361–371, 2016.

R. McNally, A. Alqudah, D. Obradovic, and L. McClements, “Elucidating the pathogenesis of pre-eclampsia using in vitro models of spiral uterine artery remodelling,” Current Hypertension Reports, vol. 19, no. 11, p. 93, 2017.

A. N. Sharp, A. E. P. Heazell, I. P. Crocker, and G. Mor, “Placental apoptosis in health and disease,” American Journal of Reproductive Immunology, vol. 64, no. 3, pp. 159–169, 2010.

K. Chau, A. Hennessy, and A. Makris, “Placental growth factor and pre-eclampsia,” Journal of Human Hypertension, vol. 31, no. 12, pp. 782–786, 2017.

D. McAninch, C. T. Roberts, and T. Bianco-Miotto, “Mechanistic insight into long noncoding RNAs and the placenta,” International Journal of Molecular Sciences, vol. 18, no. 7, p. 1371, 2017.

G. A. Cipolla, J. C. De Oliveira, A. Salviano-Silva et al., “Long non-coding RNAs in multifactorial diseases: another layer of complexity,” Non-coding RNA, vol. 4, no. 2, p. 13, 2018.

X. Song, X. Luo, Q. Gao, Y. Wang, Q. Gao, and W. Long, “Dysregulation of LncRNAs in placenta and pathogenesis of preeclampsia,” Current Drug Targets, vol. 18, no. 10, pp. 1165–1170, 2017.

L. Yu, M. Chen, D. Zhao et al., “The H19 gene imprinting in normal pregnancy and pre-eclampsia,” Placenta, vol. 30, no. 5, pp. 443–447, 2009.

Y. Zhang, Y. Zou, W. Wang et al., “Down-regulated long non-coding RNA MEG3 and its effect on promoting apoptosis and suppressing migration of trophoblast cells,” Journal of Cellular Biochemistry, vol. 116, no. 4, pp. 542–550, 2015.

Q. Zuo, S. Huang, Y. Zou et al., “The Lnc RNA SPRY4-IT1 modulates trophoblast cell invasion and migration by affecting the epithelial-mesenchymal transition,” Scientific Reports, vol. 6, no. 1, article 37183, 2016.

Y. Xu, Z. Ge, E. Zhang et al., “The lncRNA TUG1 modulates proliferation in trophoblast cells via epigenetic suppression of RND3,” Cell Death & Disease, vol. 8, no. 10, article e3104, 2017.

B. R. Muys, J. C. C. Lorenzi, D. L. Zanette et al., “Placenta-enriched lincRNAs MIR503HG and LINC00629 decrease migration and invasion potential of JEG-3 cell line,” PLoS One, vol. 11, no. 3, article e0151560, 2016.

L. Wu, W. Y. Song, Y. Xie et al., “miR-181a-5p suppresses invasion and migration of HTR-8/SVneo cells by directly targeting IGF2BP2,” Cell Death & Disease, vol. 9, no. 2, p. 16, 2018.

J. Chen and R. A. Khalil, “Matrix metalloproteinases in normal pregnancy and preeclampsia,” Progress in Molecular Biology and Translational Science, vol. 148, pp. 87–165, 2017.

J. E. Davies, J. Pollheimer, H. E. J. Yong et al., “Epithelial-mesenchymal transition during extravillous trophoblast differentiation,” Cell Adhesion & Migration, vol. 10, no. 3, pp. 310–321, 2016.

R. Aouache, L. Biquard, D. Vaiman, and F. Miralles, “Oxidative stress in preeclampsia and placental diseases,” International Journal of Molecular Sciences, vol. 19, no. 5, p. 1496, 2018.

J. P. Granger, F. T. Spradley, and B. A. Bakrania, “The endothelin system: a critical player in the pathophysiology of preeclampsia,” Current Hypertension Reports, vol. 20, no. 4, p. 32, 2018.

H. Wang, L. Liang, Q. Dong et al., “Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma,” Theranostics, vol. 8, no. 10, pp. 2814–2829, 2018.

Y. Xu, Y. Lian, Y. Zhang et al., “The long non-coding RNA PVT1 represses ANGPTL4 transcription through binding with EZH2 in trophoblast cell,” Journal of Cellular and Molecular Medicine, vol. 22, no. 2, pp. 1272–1282, 2018.

Y. Zou, Q. Li, Y. Xu et al., “Promotion of trophoblast invasion by lncRNA MVIH through inducing Jun-B,” Journal of Cellular and Molecular Medicine, vol. 22, no. 2, pp. 1214–1223, 2018.

X. Liu, H. Chen, W. Kong et al., “Down-regulated long non-coding RNA-ATB in preeclampsia and its effect on suppressing migration, proliferation, and tube formation of trophoblast cells,” Placenta, vol. 49, pp. 80–87, 2017.

A. Winer, S. Adams, and P. Mignatti, “Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes,” Molecular Cancer Therapeutics, vol. 17, no. 6, pp. 1147–1155, 2018.

E. Staun-Ram, S. Goldman, D. Gabarin, and E. Shalev, “Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion,” Reproductive Biology and Endocrinology, vol. 2, no. 1, p. 59, 2004.

B. Peng, H. Zhu, C. Klausen, L. Ma, Y. L. Wang, and P. C. K. Leung, “GnRH regulates trophoblast invasion via RUNX2-mediated MMP2/9 expression,” MHR: Basic Science of Reproductive Medicine, vol. 22, no. 2, pp. 119–129, 2016.

M. I. Kokkinos, P. Murthi, R. Wafai, E. W. Thompson, and D. F. Newgreen, “Cadherins in the human placenta – epithelial–mesenchymal transition (EMT) and placental development,” Placenta, vol. 31, no. 9, pp. 747–755, 2010.

M. J. Wheelock and K. R. Johnson, “Cadherins as modulators of cellular phenotype,” Annual Review of Cell and Developmental Biology, vol. 19, no. 1, pp. 207–235, 2003.

H. B. Zhao, C. Wang, R. X. Li et al., “E-cadherin, as a negative regulator of invasive behavior of human trophoblast cells, is down-regulated by cyclosporin A via epidermal growth factor/extracellular signal-regulated protein kinase signaling pathway,” Biology of Reproduction, vol. 83, no. 3, pp. 370–376, 2010.

Y. Yu, L. Wang, W. Tang, D. Zhang, and T. Shang, “RNA interference-mediated knockdown of Notch-1 inhibits migration and invasion, down-regulates matrix metalloproteinases and suppresses NF-κB signaling pathway in trophoblast cells,” Acta Histochemica, vol. 116, no. 5, pp. 911–919, 2014.

C. Min, S. F. Eddy, D. H. Sherr, and G. E. Sonenshein, “NF-kappaB and epithelial to mesenchymal transition of cancer,” Journal of Cellular Biochemistry, vol. 104, no. 3, pp. 733–744, 2008.

J. E. Vaughan and S. W. Walsh, “Activation of NF-κB in placentas of women with preeclampsia,” Hypertension in Pregnancy, vol. 31, no. 2, pp. 243–251, 2012.

Y. Tay, J. Rinn, and P. P. Pandolfi, “The multilayered complexity of ceRNA crosstalk and competition,” Nature, vol. 505, no. 7483, pp. 344–352, 2014.

P. S. Huang, I. H. Chung, Y. H. Lin, T. K. Lin, W. J. Chen, and K. H. Lin, “The Long non-coding RNA MIR503HG enhances proliferation of human ALK-negative anaplastic large-cell lymphoma,” International Journal of Molecular Sciences, vol. 19, no. 5, p. 1463, 2018.

G. Gupta, D. K. Chellappan, T. de Jesus Andreoli Pinto, P. M. Hansbro, M. Bebawy, and K. Dua, “Tumor suppressor role of miR-503,” Panminerva Medica, vol. 60, no. 1, pp. 17–24, 2018.